A 24-year-old patient with moderate persistent asthma presen…
A 24-year-old patient with moderate persistent asthma presents for a follow-up visit after initiating combination therapy with low-dose ICS-formoterol. Over the past three months, the patient reports improved symptom control, no nighttime awakenings, and no need for oral corticosteroids. Physical exam and spirometry are stable and consistent with well-controlled asthma. According to current GINA guideline recommendations, which is the most appropriate next step in this patient’s pharmacologic management?